These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 1649971)

  • 21. Vidarabine versus acyclovir therapy in herpes simplex encephalitis.
    Whitley RJ; Alford CA; Hirsch MS; Schooley RT; Luby JP; Aoki FY; Hanley D; Nahmias AJ; Soong SJ
    N Engl J Med; 1986 Jan; 314(3):144-9. PubMed ID: 3001520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of acyclovir-resistant herpes simplex virus.
    Chilukuri S; Rosen T
    Dermatol Clin; 2003 Apr; 21(2):311-20. PubMed ID: 12757254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
    Schmit I; Boivin G
    J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acyclovir-resistant herpes in AIDS treated with foscarnet.
    Youle MM; Hawkins DA; Collins P; Shanson DC; Evans R; Oliver N; Lawrence A
    Lancet; 1988 Aug; 2(8606):341-2. PubMed ID: 2899762
    [No Abstract]   [Full Text] [Related]  

  • 25. Herpes simplex virus type-2 ulcers resistant to acyclovir in an AIDS patient--successful treatment with foscarnet.
    Stellbrink HJ; Albrecht H; Löning T; Greten H
    Klin Wochenschr; 1991 Apr; 69(6):274-8. PubMed ID: 1828096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of foscarnet for recurrent orolabial herpes: a multicentre randomized double-blind study.
    Lawee D; Rosenthal D; Aoki FY; Portnoy J
    CMAJ; 1988 Feb; 138(4):329-33. PubMed ID: 2962712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of genital herpes in HIV-infected patients.
    Aoki FY
    Herpes; 2001 Jul; 8(2):41-5. PubMed ID: 11867017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical utility of susceptibility testing of herpes simplex virus to acyclovir].
    Otegui M; Rabella N; Labeaga R; Herrero M; Margall N; Muñoz JM; Prats G
    Rev Esp Quimioter; 2001 Dec; 14(4):351-7. PubMed ID: 11856981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome.
    Birch CJ; Tachedjian G; Doherty RR; Hayes K; Gust ID
    J Infect Dis; 1990 Sep; 162(3):731-4. PubMed ID: 2167340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acyclovir-resistant herpes simplex virus infections in a bone marrow transplant population.
    Darville JM; Ley BE; Roome AP; Foot AB
    Bone Marrow Transplant; 1998 Sep; 22(6):587-9. PubMed ID: 9758349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infection.
    Safrin S; Berger TG; Gilson I; Wolfe PR; Wofsy CB; Mills J; Biron KK
    Ann Intern Med; 1991 Jul; 115(1):19-21. PubMed ID: 1646585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of acyclovir-resistant herpes simplex virus infections in patients with AIDS.
    Safrin S
    J Acquir Immune Defic Syndr (1988); 1992; 5 Suppl 1():S29-32. PubMed ID: 1602361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acyclovir resistant genital herpes virus infection in a patient with AIDS.
    Marrero M; Alvarez M; Millan JC; Mas Lago P; Soler M; Diaz M
    Acta Virol; 1991 Jan; 35(1):86-9. PubMed ID: 1683121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical effects and in vitro studies of trifluorothymidine combined with interferon-alpha for treatment of drug-resistant and -sensitive herpes simplex virus infections.
    Birch CJ; Tyssen DP; Tachedjian G; Doherty R; Hayes K; Mijch A; Lucas CR
    J Infect Dis; 1992 Jul; 166(1):108-12. PubMed ID: 1318909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
    Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
    Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Foscarnet-resistant herpes simplex virus infection in patients with AIDS.
    Safrin S; Kemmerly S; Plotkin B; Smith T; Weissbach N; De Veranez D; Phan LD; Cohn D
    J Infect Dis; 1994 Jan; 169(1):193-6. PubMed ID: 8277181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections.
    Balfour HH; Benson C; Braun J; Cassens B; Erice A; Friedman-Kien A; Klein T; Polsky B; Safrin S
    J Acquir Immune Defic Syndr (1988); 1994 Mar; 7(3):254-60. PubMed ID: 8106965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir.
    Straus SE; Takiff HE; Seidlin M; Bachrach S; Lininger L; DiGiovanna JJ; Western KA; Smith HA; Lehrman SN; Creagh-Kirk T
    N Engl J Med; 1984 Jun; 310(24):1545-50. PubMed ID: 6328297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.
    Arnulf B; Chebbi F; Lefrere F; Ait Arkoub Z; Varet B; Fillet AM
    Bone Marrow Transplant; 2001 Oct; 28(8):799-801. PubMed ID: 11781635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection.
    Wald A; Carrell D; Remington M; Kexel E; Zeh J; Corey L
    Clin Infect Dis; 2002 Apr; 34(7):944-8. PubMed ID: 11880960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.